Overview
Colorectal cancer is one of the most common types of cancer in the world, ranking 3rd among cancers that cause death in men and women. In patients diagnosed with colorectal cancer, chemotherapy treatment is planned to prolong survival as in all other cancer patients. Among the side effects of chemotherapy treatment, it is known that fatigue develops between 50-90%, which is mild for one week in 45% of patients and persists for two weeks in 33%. In the literature, the incidence of chemotherapy-induced peripheral neuropathy is reported to be between 10-100% depending on the type and dose of the drug taken. Alejandro et al. (2013) reported that the incidence of oxaliplatin-related peripheral neuropathy was 84%, which was acute in 74% of patients and permanent in 48%. In addition, anxiety disorders are among the common mental symptoms in cancer patients and their prevalence has been reported to be 10-30%.
In this study, it is aimed to reveal the effect of nursing interventions based on Levine's Conservation Model on fatigue, peripheral neuropathy and anxiety levels in colorectal cancer patients receiving chemotherapy treatment.
Eligibility
Inclusion Criteria:
- Between the ages of 18-75
- Diagnosed with primary and new colorectal cancer (Stage II and III),
- The decision to start the FOLFOX treatment protocol has been taken,
- Having a smartphone,
- Being literate,
- Ability to speak and understand Turkish,
- Open to communication and cooperation.
Exclusion Criteria:
- History of neuropathy or diabetes,
- History of hypothyroidism, renal failure,
- Hearing, speech and vision problems,
- Receiving radiotherapy or immunotherapy,
- Psychiatric diagnosis or ongoing treatment.